Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
BRIEFS
June 08, 2023
Facing the high—and rising—burden of antimicrobial resistance (AMR), Brazil has an opportunity to improve access, stewardship, and innovation for critical antimicrobials at the national, regional, and/or global level(s) by modifying procurement arrangements. Brazil is positioned for significant dome...
CASE STUDIES
May 18, 2023
Almost 140,000 people die with a drug-resistant bacterial infection in Brazil every year due in large part to shortcomings in access, stewardship, and innovation for antimicrobials. Brazil’s existing Productive Development Partnerships system could be modified to reduce incentives for overselling an...
Blog Post
May 18, 2023
Today we launched two country case studies examining policy proposals to improve antimicrobial procurement in India and Brazil (versão em português). These studies are outputs of CGD’s working group on antimicrobial procurement in low- and middle-income countries (LMICs), which is developing recomme...
Blog Post
December 14, 2022
Four new CGD pieces, released today, examine the current state of play on COVID-19 oral antivirals. Our analyses provide a deep-dive in key cross-cutting areas—demand, voluntary licensing deals for generic supply, and deployment—and offer policy actions for 2023 and beyond.
Blog Post
October 06, 2022
Despite alleged “lessons learned” from the COVID-19 pandemic about the need for early containment, getting the messaging right, and a swift rollout of diagnostics, vaccines, and therapeutics, we have seen the same blunders yet again in the monkeypox response, highlighting the inequities in the syste...
Blog Post
July 20, 2022
Get ready for Pandemic Proof, a new podcast from the Center for Global Development. Hosted by CGD's Amanda Glassman and Javier Guzman and featuring guests from around the world, Pandemic Proof will confront weaknesses in the global architecture for pandemic preparedness and response, and explore pol...